Psoriasis trials in Argentina
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Rosario
- Age
- 3 years to 64 years
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - Phase 3Taking peopleLong-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Where
- Autonomous City of Buenos Aires, Buenos Aires, C.a.b.a., CABA, Ciudad Autonoma Buenos Aires, Ciudad Autónoma Buenos Aires, Córdoba, Mendoza
- Age
- 40 years and over
- People
- 3,040 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Where
- Buenos Aires, Ciudad Autonoma de Buenos Aires, SAN M. de Tucuman
- Age
- 12 years to 17 years
- People
- 366 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06979453 · EU 2023-506296-97-00 - Phase 3Taking peopleA Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Where
- Buenos Aires, CABA, Ciudad Autonoma de Buenos Aires, Córdoba
- Age
- 4 years to 18 years
- People
- 153 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04772079 · EU 2022-502519-13-00 - No phaseTaking peopleAn Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Where
- Quilmes, Río Cuarto, San Isidro
- Age
- 18 years to 75 years
- People
- 1,200 worldwide
- Run by
- AbbVie
See details and how to joinNCT06764693